NCT03161366View on ClinicalTrials.gov

Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 28, 2018

Primary Completion Date

July 14, 2018

Study Completion Date

November 30, 2018

Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL

rVSVΔG-ZEBOV-GP

Ring vaccination with vaccination of contacts and contacts of contacts after laboratory confirmation of one Ebola Zaire case

Trial Locations (2)

1956

Epicentre, Mbarara

Unknown

Médecins Sans Frontières, Kinshasa

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

Medecins Sans Frontieres, Netherlands

OTHER

lead

Epicentre

OTHER

NCT03161366 - Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine | Biotech Hunter | Biotech Hunter